
|Articles|July 1, 1998
Supplements and Featured Publications
- New and Emerging Therapies in the Treatment of Hypertension and Congestive Heart Failure
 - Volume 4
 - Issue 7 Suppl
 
European Society of Cardiology: Angiotensin II Antagonists: Why is There So Much Excitement?
Author(s)Norman K. Hollenberg, MD
Advertisement
Articles in this issue
over 27 years ago
Participating Facultyover 27 years ago
Gene Polymorphism Influences Response to Angiotensin Blockadeover 27 years ago
New Drug Class Offers Benefits in Heart Failureover 27 years ago
Exploring the Benefits Beyond Blood Pressure ControlNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
COVID-19 Vaccination Linked to Lower Risk of Long COVID in Adolescents
2
Remote Monitoring May Improve Heart Failure Outcomes: Anitha Vijayan, MD
3
Role of MRAs in Heart Failure Treatment
4
Breast Cancer Dominating Oncology Research, Access Disparities: Gen Li, PhD
5















































